Thats for the great reply buddy. My thoughts are Jazz Pharmaceutical or one of there direct competitors will want to be part of EMD-RX5 /EMD-RX7 well before Phase 3 trials are completed, or even started IMO.
Now with there being no need for Phase 2 trials, the clock is ticking I guess.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
3.3¢ |
Change
-0.002(5.71%) |
Mkt cap ! $20.17M | |||
| Open | High | Low | Value | Volume |
| 3.4¢ | 3.4¢ | 3.2¢ | $51.43K | 1.552M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 295884 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 1185025 | 2 |
View Market Depth
| Last trade - 15.59pm 21/07/2025 (20 minute delay) ? |
| EMD (ASX) Chart |